The analysis indicates a consistent decline in antihypertensive medicine sales in Italy from 2024 to 2028. Starting from 161.4 million euros in 2024, the sales are expected to decrease annually, reaching 151.1 million euros by 2028. The year-on-year percentage variation shows a steady decrease, with a notable compound annual growth rate (CAGR) reflecting a negative trend over this five-year forecast period. Prior to 2024, data for 2023 are essential for establishing a baseline but are not provided here.

Future trends to watch for include advancements in hypertension treatment, potential shifts toward preventive care, and changes in healthcare policies. Monitoring these factors is crucial as they could influence the market dynamics and alter the demand for antihypertensive medications.

Download as XLS

More about Antihypertensive Industry 2025-2029